In this exploratory analysis, we investigated whether the efficacy of trastuzumab emtansine T DM1, an antibody drug conjugate comprised of the cytotoxic agent DM1 linked to the HER2 targeted antibody trastuzumab, was correlated with the expression of specific biomarkers in the phase III EMILIA study <a href=http://bestcialis20mg.com/>buying cialis online reviews</a>